Ascentage Pharma Group International (AAPG)

Iteris Stock Forecast

Stock Price Forecast

There is currently no analyst price target forecast available for Iteris.

Price Target: $ (0.00%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	n/a	n/a	n/a	n/a
Change	n/a	n/a	n/a	n/a

Analyst Ratings

According to 1 stock analyst, the rating for Iteris is "Buy". This means that the analyst believes this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jul '25	Aug '25
Strong Buy	0	0
Buy	1	1
Hold	0	0
Sell	0	0
Strong Sell	0	0
Total	1	1

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Brian Cheng JP Morgan	JP Morgan	Buy Initiates n/a	Buy	Initiates	n/a	n/a	Mar 27, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

541.62M

Decreased by -44.77%

from 980.65M

Revenue Next Year

2.73B

Increased by 404.41%

from 541.62M

EPS This Year

-3.10

from -1.34

EPS Next Year

2.33

from -3.10

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	12.45M	27.91M	209.71M	221.98M	980.65M	541.62M	2.73B	1.77B
Revenue Growth	-14.22%	124.18%	651.38%	5.85%	341.77%	-44.77%	404.41%	-35.07%
EPS	-3.14	-3.07	-3.35	-3.28	-1.34	-3.10	2.33	-0.05
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	17.64	-
No. Analysts	-	-	-	-	-	11	11	6

Financial currency is CNY. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	653.1M	3.4B	2.9B
Avg	541.6M	2.7B	1.8B
Low	414.5M	1.8B	758.9M

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	-33.4%	523.3%	7.7%
Avg	-44.8%	404.4%	-35.1%
Low	-57.7%	230.1%	-72.2%

EPS Forecast

EPS	2025	2026	2027
High	-2.27	4.34	3.15
Avg	-3.10	2.33	-0.05
Low	-3.92	-0.90	-1.62

EPS Growth

EPS Growth	2025	2026	2027
High	-	-	35.1%
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.